$500K on the table in AI vs. COVID contest

Nonprofit competition organizer XPrize is partnering with global tech consultancy Cognizant to award AI innovators in a pandemic response challenge.

Total prize purse: half a million dollars.

XPrize opened the contest Nov. 17, saying the money will go to teams that develop outstanding AI models for predicting COVID’s spread and prescribing cost-effective ways to thwart it.

Amir Banifatemi, XPrize’s chief innovation and growth officer, says the entries “could be a game changer when it comes to using data and AI to create a route to recovery via a range of economic scenarios created by the competing teams. With vaccines on the horizon, these predictive and prescriptive models for opening society will continue to be valuable for the foreseeable future.”

The challenge will close in February. Details here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.